IP Verse

A Tablet Dosage Form For Buccal Absorption Of Active Ingredients

Patent No. EP3793533 (titled "A Tablet Dosage Form For Buccal Absorption Of Active Ingredients") was filed by Fertin Pharma on May 15, 2019. The application was issued on Jul 5, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
NICOVENTURESApr 5, 2024D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3793533

FERTIN PHARMA
Application Number
EP19729180A
Filing Date
May 15, 2019
Status
Granted And Under Opposition
Jun 2, 2023
Publication Date
Jul 5, 2023
External Links
Slate, Register , Google Patents